11-K 1 form11kaug10.htm FORM 11-K form11kaug10.htm



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
 
 
FORM 11-K
 
ANNUAL REPORT
 
PURSUANT TO SECTION 15(d) OF THE
 
SECURITIES EXCHANGE ACT OF 1934
 
 

 
 
 
(X)
ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 [NO FEE REQUIRED].
 
For the fiscal year ended March 31, 2010
 
OR
 
 
( )
TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 [NO FEE REQUIRED].
 
For the transition period from ____ to ____.
 
 
Commission File No. 0-23832
 
 
   A.  Full title of the plan and address of the plan, if different from that of the issuer named below:
 
 
PSS WORLD MEDICAL, INC. SAVINGS PLAN
 
  
   B.  Name of issuer of the securities held pursuant to the plan and the address of its principal executive office:
 
 
PSS WORLD MEDICAL, INC.
 
4345 Southpoint Boulevard
 
Jacksonville, Florida 32216
 
 
 

 
 
 
REQUIRED INFORMATION
 
 
 
The PSS World Medical, Inc. Savings Plan (the “Plan”) is subject to the requirements of the Employee Retirement Income Security Act of 1974 (“ERISA”).  The following financial statements and schedules of the Plan have been prepared in accordance with the financial reporting requirements of ERISA.
 

 
 

 



 
PSS WORLD MEDICAL, INC. SAVINGS PLAN
 
March 31, 2010 and 2009
 
 
 
Table of Contents
 
 
 
       
   
Page(s)
 
       
Report of Independent Registered Public Accounting Firm
  1  
       
Financial Statements:
     
       
Statements of Net Assets Available for Benefits
  2  
       
Statement of Changes in Net Assets Available for Benefits
  3  
       
Notes to Financial Statements
  4  
       
Supplemental Schedule*
     
       
Schedule H, Line 4i-Schedule of Assets (Held at End of Year)
  13  
       
Signature
  15  
       
Exhibit Index
  16  
       
 
* Other schedules required by 29 CFR 2520.103–10 of the Department of Labor’s Rules and Regulations for Reporting and Disclosure under ERISA have been omitted because they are not applicable, or are not required for participant–directed investment transactions.
 
 
 

 
 
Report of Independent Registered Public Accounting Firm
 
 
 
To the Participants and Administrator of the
PSS World Medical, Inc. Savings Plan:
 
We have audited the accompanying statements of net assets available for benefits of PSS World Medical, Inc. Savings Plan as of March 31, 2010 and 2009, and the related statement of changes in net assets available for benefits for the year ended March 31, 2010. These financial statements are the responsibility of the Plan’s management. Our responsibility is to express an opinion on these financial statements based on our audits.
 
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States).  Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. We were not engaged to perform an audit of the Plan's internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Plan's internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
 
In our opinion, the financial statements referred to above present fairly, in all material respects, the net assets available for benefits of PSS World Medical, Inc. Savings Plan as of March 31, 2010 and 2009, and the changes in net assets available for benefits for the year ended March 31, 2010, in conformity with U.S. generally accepted accounting principles.
 
Our audits were performed for the purpose of forming an opinion on the basic financial statements taken as a whole. The accompanying supplemental schedule:  Schedule H, Line 4i-Schedule of Assets (Held at End of Year) as of March 31, 2010, is presented for the purpose of additional analysis and is not a required part of the basic financial statements but is supplementary information required by the Department of Labor’s Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. This supplemental schedule is the responsibility of the Plan’s management. This supplemental schedule has been subjected to the auditing procedures applied in the audit of the basic financial statements and, in our opinion, is fairly stated in all material respects in relation to the basic financial statements taken as a whole.
 
 
/s/ The GriggsGroup CPAs
 
August 25, 2010
Certified Public Accountants
Ponte Vedra Beach, Florida

 
1

 

PSS WORLD MEDICAL, INC. SAVINGS PLAN
Statements of Net Assets Available for Benefits
March 31, 2010 and 2009
 
 
 
 
 
 
   
2010
 
2009
Assets
           
Investments, at fair value
  $ 146,158,733     $ 98,197,025  
Receivables:
               
Employee contribution
    730,713       -  
Employer contribution
    636,901       -  
Total receivables
 
­1,367,614
      -  
Total assets
    147,526,347       98,197,025  
Liabilities
               
Payables
    332,159       394,581  
Net assets available for benefits, at fair value
    147,194,188       97,802,444  
Adjustment from fair value to contract value for
               
fully benefit-responsive investment contracts
    85,559       1,112,387  
Net assets available for benefits
  $ 147,279,747     $ 98,914,831  
 
 
 
 
 
The accompanying notes are an integral part of these financial statements.
 

 
2

 

PSS WORLD MEDICAL, INC. SAVINGS PLAN
Statement of Changes in Net Assets Available for Benefits
Year ended March 31, 2010
 
 
 
 
 
   
2010
Additions to net assets available for benefits:
     
Investment income:
     
Net appreciation in fair value of investments
  $ 42,674,355  
Dividends and interest income
    888,150  
Net investment gain
    43,562,505  
Contributions:
       
Participant
    9,882,342  
Employer
    2,273,410  
Rollovers from qualified plans
    266,225  
Total contributions
    12,421,977  
Total additions
    55,984,482  
Deductions from net assets available for benefits:
       
Benefits paid to participants
    (7,608,016 )
Administrative expenses
    (11,550 )
Total deductions
    (7,619,566 )
Total increase in net assets available for benefits
    48,364,916  
Net assets available for benefits:
       
Beginning of year
    98,914,831  
End of year
  $ 147,279,747  

 
 
 
 
The accompanying notes are an integral part of these financial statements.
 

 
3

 

(1)  Description of Plan
 
The following description of the PSS World Medical, Inc. Savings Plan (the “Plan”) provides only general information. Participants should refer to the plan document for a more complete description of the Plan’s provisions.
 
(a)  General
 
The Plan is a defined contribution retirement plan covering substantially all employees of PSS World Medical, Inc. and its subsidiaries (the “Company” or “employer”). The Plan was created under the provisions of Section 401(a) of the Internal Revenue Code (the “IRC”) and includes a qualified deferred arrangement, as described in Section 401(k) of the IRC, for the benefit of eligible employees of the Company. The Plan also has the features of an employee stock ownership plan (“ESOP”), whereby employee and employer contributions can be invested in the PSS World Medical, Inc. unitized stock fund, which means participants do not actually own shares of PSS World Medical, Inc. common stock but rather own an interest in the unitized stock fund. The Plan is subject to the provisions of the Employee Retirement Income Security Act of 1974, (“ERISA”), as amended.
 
(b)  Eligibility
 
Any employee of the Company is eligible to participate in the Plan upon completing 30 days of service. Plan entry dates are the first day of each month within the Plan year.
 
(c)  Contributions
 
The Plan is funded through voluntary employee salary deferrals and employer contributions. Participants can elect to defer up to 85% but not less than 1% of compensation, as defined by the Plan and as limited by requirements of the IRC. Participants who have attained age 50 before the close of the calendar year are eligible to make an additional elective deferral contribution. Participant elective contributions are invested by the Trustee in the investment options (mainly mutual funds and employer securities) as directed by the participant. The Plan also allows participants to make elective contributions from bonuses.  On December 17, 2009, the Plan was amended to exclude special discretionary bonuses from compensation for the purpose of calculating participant and Company matching contributions.
 
The Company may make the following types of contributions: (i) Supplemental ESOP matching contributions, (ii) ESOP matching contributions, (iii) Non-ESOP matching contributions, (iv) ESOP employer contributions, (v) Employer discretionary contributions, and (vi) Qualified non-elective contributions.
 
Supplemental ESOP Matching Contributions
 
For the Plan year ended March 31, 2010, the Company made no Supplemental ESOP Matching Contributions.
 
ESOP Matching Contributions
 
For the Plan year ended March 31, 2010, the Company made no ESOP Matching Contributions.
 

 
4

 

Non-ESOP Matching Contributions
 
The Company’s board of directors may elect annually to make a discretionary contribution in the form of a non-ESOP matching contribution (contributions to be invested at the direction of the participant). Such contributions are allocated to participants based on the formula established by the board of directors. The board of directors also determines the percentage of participant elective contributions to be matched as well as the maximum amount of match to be contributed. A participant must make elective salary deferrals to be eligible for such matching contributions.
 
Non-ESOP Matching Contributions for each eligible participant are equal to the lesser of (i) 50% of a participant’s elective deferral amount up to 6% of a participant’s compensation for the Plan year or (ii) $1,250. This Non-ESOP Matching Contribution is subject to a six-year vesting schedule, as described in Note 1(d), Vesting. The Non-ESOP Matching Contributions for the Plan year ended March 31, 2010 were $1,820,831, of which $1,652,663 was funded by the Company and $168,168 was covered by forfeitures already in the Plan.
 
ESOP Employer Contributions
 
There were no ESOP employer contributions for the Plan year ended March 31, 2010.
 
Employer Discretionary Contribution
 
The Company’s board of directors may also elect annually to make employer discretionary contributions. For the Plan year ended March 31, 2010, such contributions were made to non-highly compensated employees who were employed on the last day of the Plan year. The amount of such contributions was equal to 0.5% of each non-highly compensated employee’s compensation for Plan year ended March 31, 2010.  Employer discretionary contributions were $620,716, recorded in Employer contribution receivables on the Statements of Net Assets Available for Benefits as of Plan year ended March 31, 2010.
 
Qualified Non-Elective Contributions
 
The Company’s board of directors may also elect annually to make qualified non-elective contributions. Such contributions may be allocated to a limited number of non-highly compensated employees and are only made to eliminate potential discrimination with respect to participant elective contributions or employer matching contributions that would otherwise favor highly compensated employees. There were no qualified non-elective contributions for the Plan year ended March 31, 2010.
 

 
5

 

(d)  Vesting
 
Participants are immediately vested in their contributions. Participants are vested in the Company’s ESOP matching contributions, Non-ESOP matching contributions, ESOP employer contributions, and earnings thereon based on years of continuous service, as defined in the Plan, according to the following schedule:
 
Less than two years of service
  0 %
Two years but less than three years
  20 %
Three years but less than four years
  40 %
Four years but less than five years
  60 %
Five years but less than six years
  80 %
Six years or more
  100 %
 
In the event of total and permanent disability or death, a participant shall become 100% vested in the participant’s account balance.
 
(e)  Forfeited Accounts
 
Nonvested portions of the Company’s discretionary contributions are forfeited as of a participant’s termination date and are used to reduce future Company matching contributions. During the Plan year ended March 31, 2010, forfeitures of nonvested accounts totaled $80,894.  Forfeitures used to reduce Company matching contributions were $168,168 for the Plan year ended March 31, 2010. There were no forfeitures used to reduce employer matching contributions for the Plan year ended March 31, 2009.  As of March 31, 2010 and March 31, 2009, forfeited, nonvested accounts of $4,279 and $88,553, respectively, were reflected in the accompanying Statements of Net Assets Available for Benefits.
 
(f)  Benefits Paid to Participants
 
Upon retirement, death, disability, or other severance of employment, a participant or his/her beneficiary may elect to receive an amount equal to the value of the participant’s vested interest in the participant’s account. Balances in participant accounts are paid in a single lump sum.
 
Participants who have an account balance in the Plan’s unitized stock fund will have their account balances distributed in shares of the Company’s common stock (with fractional shares paid in cash) or cash as elected by the participant with payment to the participant at their direction. On March 28, 2005, the Plan was amended to address federally mandated automatic rollovers, where certain distributions may be rolled over to an Individual Retirement Plan. On November 11, 2008, the Plan was amended to comply with the final Treasury regulations under section 415 of the IRC which amended the definition of compensation under the Plan to include severance.
 
(g)  Participant Loans
 
The Plan does not permit participant loans.
 

 
6

 

(h)  Participant Accounts
 
Each participant’s account is credited with the participant’s contributions, the Company’s contribution, and an allocation of Plan earnings. Allocations are based on participant earnings or account balances, as defined. The benefit to which a participant is entitled is the benefit that can be provided from the participant’s vested account.
 
(i)  Voting Rights
 
Each participant is entitled to exercise voting rights attributable to the shares allocated to his or her account and is notified by the Transfer Agent of the Company prior to the time that such rights are to be exercised. The Trustee will vote any allocated shares according to the instructions given by a participant. If no instructions are given to the Trustee by a participant, the Trustee will vote any allocated shares on behalf of the collective best interest of plan participants and beneficiaries.
 
(2)  Summary of Significant Accounting Policies
 
(a)  Basis of Accounting
 
The accompanying financial statements have been prepared on the accrual basis of accounting.
 
(b)  Use of Estimates
 
The preparation of the financial statements in conformity with U.S. generally accepted accounting principals (“GAAP”) requires the Plan’s management to use estimates and assumptions that affect the accompanying financial statements and disclosures. Actual results could differ from these estimates.
 
(c)  Income and Expense Recognition
 
Interest income is recorded as earned on the accrual basis of accounting. Dividend income is recorded on the ex-dividend date. Net appreciation or depreciation in fair value of investments is allocated on a daily basis to participant accounts. Purchases and sales of investments are recorded on a trade date basis.
 
Management fees and operating expenses charged to the Plan for investments in the mutual funds are deducted from income earned on a daily basis and are not separately reflected.  Consequently, management fees and operating expenses are reflected as a reduction of investment return for such investments, allocated to the individual accounts.
 
(d)  Investment Valuation
 
Investments in mutual funds are stated at fair value, which are based on published market quotations on national exchanges. Investments in common collective trusts are stated at the fair value based on the underlying unit values reported using audited financial statements of the collective trust and changes in such amounts through the Plan’s year end. The Plan’s unitized stock fund as of March 31, 2010 is valued at a unit value determined by the amount of shares of common stock and cash held within the unitized stock fund.
 

 
7

 

Investments in the accompanying Statements of Net Assets Available for Benefits include an investment in a common collective trust, ABN AMRO Income Plus Fund, which includes fully benefit responsive investment contracts recognized at fair value. However, contract value is the relevant measurement attribute for that portion of net assets available for benefits of a defined-contribution plan attributable to fully benefit-responsive investment contracts because contract value is the amount participants would receive if they were to initiate permitted transactions under the terms of the Plan. Accordingly, the Statements of Net Assets Available for Benefits presents the fair value of the investment contracts as well as the adjustment of the fully benefit-responsive investment contracts from fair value to contract value. The Statement of Changes in Net Assets Available for Benefits is prepared on a contract value basis.
 
(e)  Payment of Benefits
 
Benefits are recorded when paid.
 
(f)  Administrative Expenses
 
Administrative expenses reflected in the Statement of Changes in Net Assets Available for Benefits of $11,550 represent distribution and redemption fees paid by participants. All other Plan expenses were paid by the Company for the Plan year ended March 31, 2010.
 
(g)  Recent Accounting Pronouncements
 
In June 2009, the Financial Accounting Standards Board (“FASB”) issued guidance that establishes the FASB Accounting Standards Codification (the “Codification”) as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in conformity with U.S. GAAP. The Codification supersedes all existing accounting and reporting standards other than the rules of the Securities and Exchange Commission (“SEC”). Updates to the Codification are being issued as Accounting Standards Updates, which will also provide background information about the guidance, and provide the basis for conclusions on changes in the Codification. The Codification became effective for the Plan during the Plan year end March 31, 2010, and did not affect the accounting policies of the Plan or existing GAAP.
 
In September 2009, the FSAB issued new accounting guidance which updated fair value measurement of investments in certain entities that calculate net asset value per share (or its equivalent). This update applies to investments that do not have a readily determinable fair value and are held by an entity that is required to report investment assets at fair value. This update creates a practical expedient to measure the fair value of such investments on the basis of the net asset value per share (or its equivalent) and requires disclosures by major category of the investments about the attributes of investments, such as the nature of any restrictions of the investor's ability to redeem its investments at the measurement date, any unfunded commitments, and the investment strategies of the investees. The adoption of this update did not impact the Plan's financial statements. See Note 4, Investment, for additional disclosures on the Plan’s investment in common collective trusts.
 

 
8

 

In January 2010, the FASB issued guidance which requires additional disclosures regarding fair value measurements, amends disclosures about post-retirement benefit plan assets and provides clarification regarding the level of disaggregation of fair value disclosures by investment class. This guidance is effective for interim and annual reporting periods beginning after December 15, 2009, except for certain Level 3 activity disclosure requirements that will be effective for reporting periods beginning after December 15, 2010. The Plan is currently evaluating the impact of adopting this guidance.
 
 (3)  Fair Value Measurements
 
Assets and liabilities recorded at fair value are measured using a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include:
 
Level 1:  Inputs using unadjusted quoted prices for identical assets or liabilities in an active market that the Company has the ability to access.
 
Level 2:  Inputs other than quoted prices in markets that are observable for the asset or liability, either directly or indirectly.
 
Level 3:  Inputs that are both significant to the fair value measurement and unobservable.
 
A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.
 
The following is a description of the valuation methods used for assets measured at fair value.
 
Mutual funds: The fair values of these securities are based on observable market quotations for identical assets and are priced on a daily basis at the close of business.
 
Common collective trusts: The fair value of the investments in the common/collective trusts is determined by the fund trustee based on the fair value of the underlying securities within the fund, which represent the net asset value of the shares held by the Plan at year end.
 
PSS World Medical, Inc. unitized stock fund: The fair values of these securities are based on observable market quotations for identical assets and are valued at the closing price reported on the active market on which the individual securities are traded plus uninvested cash portion.
 
The methods described above may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. Furthermore, while the Plan believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement.
 
As of March 31, 2010 and 2009, the fair value of the Plan’s financial assets were measured using Level 1 or Level 2 inputs.  The following table presents the Plan's assets, by major category, at fair value on a recurring basis as of March 31, 2010 and 2009.
 
March 31, 2010
 
Level 1
 
Level 2
 
Total
Common collective trusts
  $ -     $ 15,383,458     $ 15,383,458  
Mutual funds:
                       
U.S large cap equity
    28,551,195       -       28,551,195  
U.S. mid cap equity
    16,352,444       -       16,352,444  
U.S. small cap equity
    12,159,709       -       12,159,709  
International equity
    20,279,952       -       20,279,952  
Bond funds
    18,036,255       -       18,036,255  
PSS World Medical, Inc. unitized stock fund
    35,395,720       -       35,395,720  
Total
  $ 130,775,275     $ 15,383,458     $ 146,158,733  
                         
March 31, 2009
 
Level 1
 
Level 2
 
Total
Common collective trusts
  $ -     $ 13,829,399     $ 13,829,399  
Mutual funds:
                       
U.S large cap equity
    18,035,502       -       18,035,502  
U.S. mid cap equity
    10,229,100       -       10,229,100  
U.S. small cap equity
    6,655,210       -       6,655,210  
International equity
    12,221,751       -       12,221,751  
Bond funds
    13,461,560       -       13,461,560  
PSS World Medical, Inc. unitized stock fund
    23,764,503       -       23,764,503  
Total
  $ 84,367,626     $ 13,829,399     $ 98,197,025  
 

 
9

 

(4)  Investments
 
All investment elections are participant-directed funds. The following presents investments that represent 5% or more of the Plan’s net assets as of March 31, 2010 and 2009:
 
 
   
2010
   
2010
   
2009
   
2009
 
Description of Asset
 
Units
   
Value
   
Units
   
Value
 
PSS World Medical Inc. unitized stock fund
    1,684,810     $ 35,395,720       1,833,637     $ 23,764,503  
ABN AMRO Income Plus Fund*
    2,266,423       15,383,458       2,226,097       13,829,399  
PIMCO Total Return Admin Fund
    1,195,631       13,199,766       999,947       10,129,464  
American Funds Growth Fund of America
    412,367       11,562,760                  
T. Rowe Price Growth Stock Fund
                    399,101       7,594,885  
Janus Perkins Mid Cap Value Fund
    503,305       10,524,114       537,586       7,590,720  
Principal Large Cap S&P 500 Index
    1,212,378       10,026,368       1,132,072       6,384,886  
American EuroPacific Growth Fund
    253,516       9,790,798       233,624       6,022,819  
Jennison Dryden Small Company A Fund
    443,647       7,732,768                  
William Blair Small Cap Growth Fund
                    375,139       4,486,660  
All other assets less than 5%
            32,542,981               18,393,689  
Total
          $ 146,158,733             $ 98,197,025  
 
* The contract value for the ABN AMRO Income Plus Fund is $15,469,017 and $14,941,786 as of March 31, 2010 and 2009, respectively.
 
 
As of March 31, 2010 and 2009, the Plan invested in a common collective trust, ABN AMRO’s Income Plus Fund. The Income Plus Fund invests primarily in guaranteed investment contracts (“GICs”), money market funds, money market instruments, repurchase agreements, private placements, bank investment contracts and synthetic GICs. Contract value, as reported to the Plan, represents contributions made under the contract, plus earnings, less participant withdrawals and administrative expenses. The Plan has no unfunded commitments related to the Income Plus Fund and this fund is redeemable on a daily basis without restriction.  The Plan’s interest in the Income Plus Fund is calculated by applying the Plan’s ownership percentage in the Income Plus Fund to the total fair value of the Income Plus Fund.
 
The interest crediting rate as of March 31, 2010 and 2009 was 2.22% and 3.86%, respectively. The interest crediting rate is calculated based upon many factors, including current economic and market conditions, the general interest rate environment, the amount and timing of participant contributions, transfers, and withdrawals and the duration of the fixed-income investments that underlie the wrap contracts.
 
The average market yield of the Income Plus Fund for the year ended March 31, 2010 was 2.64%.
 
During the year ended March 31, 2010, the Plan’s investments (including gains and losses on investments bought and sold, as well as held during the year) appreciated in value as follows:
 
Mutual funds
$ 27,358,344  
PSS World Medical, Inc. unitized stock fund
  14,313,342  
Bond funds
  779,944  
Common collective trusts
  222,725  
Net appreciation in fair value of investments
$ 42,674,355  
 
 

 
10

 

(5)  Tax Status
 
The Internal Revenue Service has determined and informed the Company by a letter dated July 21, 2003, that the Plan and related trust are designed in accordance with applicable sections of the IRC. Although the Plan has been amended since receiving the determination letter, the Plan administrator believes that the Plan continues to be designed and is currently being operated in compliance with the applicable requirements of the IRC and the Plan document.  During Plan year March 31, 2010, the Plan was notified by the Internal Revenue Service (“IRS”) that Plan year ended March 31, 2008 was under examination.  There have been no further developments on, or findings from, the examination.  On April 1, 2009, the Plan was amended and restated and filed a Form 5300, Application for Determination for Employee Benefit Plan on January 29, 2010, accordingly.
 
(6)  Plan Termination
 
Although it has not expressed any intent to do so, the Company has the right under the Plan to discontinue its contributions at any time and to terminate the Plan subject to the provisions of ERISA. In the event of plan termination, participants would become fully vested in their employer contributions and earnings thereon.
 
(7)  Related Party Transactions
 
As of March 31, 2010 and 2009, the Plan owned 1,480,768 and 1,647,884 shares of the Company’s common stock, respectively, which represents approximately 2.6% and 2.7% of the outstanding common stock of the Company, respectively.  These shares along with cash represent 1,684,810 and 1,833,637 units of the unitized stock fund as of March 31, 2010 and 2009, respectively.
 
As of March 31, 2010 and 2009, payables to participants to satisfy the Actual Deferral Percentage Test totaled $319,390 and $381,680, and payables to Principal Financial Group representing pending trades totaled $12,769 and $12,901, respectively.  Principal Financial Group is the trustee as defined by the Plan and, therefore, these transactions qualify as party-in-interest transactions.  Fees paid by the Plan to the trustee for administrative services amounted to $11,550 for the Plan year ended March 31, 2010.
 
(8)  Risk and Uncertainties
 
The Plan invests in various investment securities including the Company’s common stock (approximately 24% of net assets available for benefits as of March 31, 2010), as described in Note 4, Investments. Investment securities are exposed to various risks such as interest rate, market, and credit risks. Due to the level of risk associated with certain investment securities, it is at least reasonably possible that changes in the values of investment securities will occur in the near term and that such changes could materially affect participants’ account balances and the amounts reported in the Statements of Net Assets Available for Benefits.
 

 
11

 

(9)  Reconciliation of Financial Statements to Form 5500
 
The following is a reconciliation of net assets available for benefits per the financial statements as of March 31, 2010 and 2009 to Form 5500:
 
    
2010
   
2009
 
Net assets available for benefits per the financial statements
  $ 147,279,747     $ 98,914,831  
Benefits allocated to participants
    332,159       394,581  
Adjustment to fair value from contract value for investment
               
relating to fully benefit-responsive investment contracts
    (85,559 )     (1,112,387 )
Net assets available for benefits per Form 5500
  $ 147,526,347     $ 98,197,025  
 
The following is a reconciliation of the change in net assets available for benefits per the financial statements as of March 31, 2010 to Form 5500:
 
    
2010
 
Change in net assets available for benefits per the financial statements
  $
48,364,916
 
Benefits allocated to participants
   
332,159
 
Prior year benefits allocated to participants
   
(394,581
)
Adjustment to fair value from contract value for investment    
 
 
        relating to fully benefit-responsive investment contracts    
(85,559
)
Prior year adjustment to fair value from contract value for investment        
relating to fully benefit-responsive investment contracts
   
1,112,387
 
Net income per Form 5500
  $
49,329,322
 


 
12

 

PSS World Medical, Inc. Savings Plan
 
EIN 59-2280364. Plan # 001
 
Schedule H, Line 4i – Schedule of Assets (Held at End of Year) March 31, 2010
 
   
Identity of party involved
 
Description of investment
 
Current Value
 
 *  
PSS World Medical, Inc.
 
PSS World Medical, Inc. common stock 1,684,810 units
  $ 35,395,720  
   
ABN AMRO Investment Trust Company
 
ABN AMRO Income Plus Fund
    13,154,057  
   
Janus Capital Group
 
Janus Perkins Mid Cap Value Fund
    9,290,208  
   
Capital Research and Management Company
 
American Funds Growth Fund of America R3 Fund
    9,226,031  
   
Pacific Investment Management Company
 
PIMCO Total Return Admin Fund
    8,552,603  
   
Pacific Investment Management Company
 
PIMCO Real Return Admin Fund
    2,081,063  
   
Prudential Funds
 
Jennison Dryden Small Company A Fund
    7,616,853  
   
Capital Research and Management Company
 
American Europacific Growth Fund
    6,132,461  
   
Oppenheimer Funds
 
Oppenheimer Global Fund
    5,495,119  
 *  
Principal Financial Group
 
Principal LargeCap S&P 500 Index Fund
    5,412,755  
   
Van Kampen Investments
 
Invesco Van Kampen Growth & Income Fund
    4,612,707  
   
Royce & Associates
 
Royce Pennsylvania Mutual Fund
    3,462,266  
   
Goldman Sachs Asset Management
 
Goldman Sachs Growth Opportunities Fund
    3,158,008  
   
Harbor Capital Advisors
 
Harbor International Investor Fund
    1,301,598  
 *  
Principal Financial Group
 
Principal MidCap S&P 400 Index R5 Fund
    338,647  
 *  
Principal Financial Group
 
Principal SmallCap S&P 600 Index R5 Fund
    264,203  
   
American Century Investment Management
 
American Century Inflation Adjusted Bond Fund
    51,717  
                 
 *  
Principal Financial Group
 
PSS World Medical, Inc., Moderate Portfolio, 1,875,037 units
       
       
PIMCO Total Return Admin Fund
    2,888,750  
      *  
Principal LargeCap S&P 500 Index R5 Fund
    2,164,739  
         
American Europacific Growth Fund
    1,714,384  
         
Harbor International Investor Fund
    1,710,452  
         
PIMCO Real Return Admin Fund
    1,612,356  
         
ABN AMRO Income Plus Fund
    1,307,781  
         
Invesco Van Kampen Growth & Income Fund
    1,085,685  
         
American Funds Growth Fund of America R3 Fund
    1,080,557  
         
Goldman Sachs Growth Opportunities Fund
    621,304  
         
Janus Perkins Mid Cap Value Fund
    611,458  
      *  
Principal MidCap S&P 400 Index R5 Fund
    469,262  
      *  
Principal SmallCap S&P 600 Index R5 Fund
    156,506  
         
Royce Pennsylvania Mutual Investors Fund
    155,422  
                15,578,656  
 *  
Principal Financial Group
 
PSS World Medical, Inc., Moderate Aggressive Portfolio, 847,403 units
       
      *  
Principal LargeCap S&P 500 Index R5 Fund
    1,172,144  
         
American Europacific Growth Fund
    973,668  
         
Harbor International Investor Fund
    971,462  
         
PIMCO Total Return Admin Fund
    655,066  
         
Invesco Van Kampen Growth & Income Fund
    622,497  
         
American Funds Growth Fund of America R3 Fund
    619,550  
         
PIMCO Real Return Admin Fund
    392,159  
      *  
Principal MidCap S&P 400 Index R5 Fund
    348,713  
         
ABN AMRO Income Plus Fund
    323,965  
         
Goldman Sachs Growth Opportunities Fund
    277,037  
         
Janus Perkins Mid Cap Value Fund
    272,638  
      *  
Principal SmallCap S&P 600 Index R5 Fund
    139,576  
         
Jennison Dryden Small Company A Fund
    70,575  
         
Royce Pennsylvania Mutual Investors Fund
    69,296  
                6,908,346  
 

 
13

 

 
 *  
Principal Financial Group
 
PSS World Medical, Inc., Aggressive Portfolio, 558,262 units
     
      *  
Principal LargeCap S&P 500 Index R5 Fund
    1,015,683   
         
Harbor International Investor Fund
    807,854   
         
American Europacific Growth Fund
    767,146   
         
Invesco Van Kampen Growth & Income Fund
    498,824   
         
American Funds Growth Fund of America R3 Fund
    494,944   
         
Goldman Sachs Growth Opportunities Fund
    270,967   
         
Janus Perkins Mid Cap Value Fund
    268,408   
      *  
Principal MidCap S&P 400 Index R5 Fund
    224,299   
      *  
Principal SmallCap S&P 600 Index R5 Fund
    89,248   
         
Jennison Dryden Small Company A Fund
    45,340   
         
Royce Pennsylvania Mutual Investors Fund
    44,480   
                4,527,193   
 *  
Principal Financial Group
 
PSS World Medical, Inc., Moderate Conservative Portfolio, 283,945 units
       
         
PIMCO Total Return Admin Fund
    599,160   
         
PIMCO Real Return Admin Fund
    367,020   
         
ABN AMRO Income Plus Fund
    321,043   
      *  
Principal LargeCap S&P 500 Index R5 Fund
    204,976   
         
American Europacific Growth Fund
    160,702   
         
Harbor International Investor Fund
    160,332   
         
Invesco Van Kampen Growth & Income Fund
    114,227   
         
American Funds Growth Fund of America R3 Fund
    113,686   
         
Janus Perkins Mid Cap Value Fund
    67,546   
      *  
Principal MidCap S&P 400 Index R5 Fund
    46,079   
         
Goldman Sachs Growth Opportunities Fund
    45,757   
      *  
Principal SmallCap S&P 600 Index R5 Fund
    23,052   
         
Royce Pennsylvania Mutual Investors Fund
    22,892   
                2,246,472   
 *  
Principal Financial Group
 
PSS World Medical, Inc., Conservative Portfolio, 181,841 units
       
         
PIMCO Total Return Admin Fund
    504,187   
         
PIMCO Real Return Admin Fund
    332,174   
         
ABN AMRO Income Plus Fund
    276,612   
      *  
Principal LargeCap S&P 500 Index R5 Fund
    56,071   
         
American Europacific Growth Fund
    42,437   
         
Harbor International Investor Fund
    42,337   
         
Invesco Van Kampen Growth & Income Fund
    28,127   
         
American Funds Growth Fund of America R3 Fund
    27,992   
      *  
Principal MidCap S&P 400 Index R5 Fund
    14,177   
         
Goldman Sachs Growth Opportunities Fund
    14,080   
         
Janus Perkins Mid Cap Value Fund
    13,856   
                1,352,050   
              $ 146,158,733  
 
* Party-in-interest
 
 
See accompanying independent registered public accounting firm’s report.
 

 
14

 

SIGNATURES
 
The Plan.  Pursuant to the requirements of the Securities Exchange Act of 1934, the trustees (or other persons who administer the employee benefit plan) have duly caused this annual report to be signed on its behalf by the undersigned, hereunto duly authorized.
 
 
Date:  August 25, 2010      
       
  PSS WORLD MEDICAL, INC. SAVINGS PLAN  
 
 
   
  By: PSS World Medical, Inc., as Plan Administrator  
         
 
By:
/s/ David M. Bronson  
    Name:      David M. Bronson   
    Title:         Executive Vice President and Chief Financial Officer  
                     (Duly Authorized Officer and Principal Financial and Accounting Officer)   


 
15

 

EXHIBIT INDEX
 
 
Exhibit
 
Number
 
   
23.1
Consent of Independent Registered Public Accounting Firm
16